Massachusetts Financial Services’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Massachusetts Financial Services's IBRX Position: Q3 2026 in Review
Massachusetts Financial Services opened a new position in ImmunityBio (IBRX) in Q3 2026: 25,223 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #997 among its holdings. This is a return to the name: Massachusetts Financial Services previously reported a position in IBRX as recently as Q1 2016.
Massachusetts Financial Services first reported a position in IBRX in Q3 2015 and has held it in 4 quarters since. The position peaked at $3.14M in Q4 2015. 404 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Massachusetts Financial Services held 25,223 shares of ImmunityBio worth $238K as of Q3 2026.
- ImmunityBio was a new Massachusetts Financial Services position in Q3 2026.
- ImmunityBio made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #997 holding.
- Massachusetts Financial Services first reported a position in ImmunityBio in Q3 2015 and has held it in 4 quarters since.
- Massachusetts Financial Services's ImmunityBio position peaked at $3.14M in Q4 2015.
- 404 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.